Home
/
Insight Molecular Diagnostics Inc.
/
Financials
/
Quarterly
Insight Molecular Diagnostics Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Insight Molecular Diagnostics Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2016
Sep 30, 2016
$0
Nov 10, 2016
Q2
2016
Jun 30, 2016
$0
Aug 11, 2016
Q1
2016
Mar 31, 2016
$0
May 16, 2016
Q1
2016
Dec 31, 2015
$0
May 16, 2016
Q3
2016
Dec 31, 2015
$0
Nov 10, 2016
Q2
2016
Dec 31, 2015
$0
Aug 11, 2016
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$260.0K
Nov 10, 2025
Q2
2025
Jun 30, 2025
$518.0K
Aug 11, 2025
Q1
2025
Mar 31, 2025
$2.14M
May 12, 2025
Q3
2025
Sep 30, 2024
$115.0K
Nov 10, 2025
Q2
2025
Jun 30, 2024
$104.0K
Aug 11, 2025
Q1
2025
Mar 31, 2024
$176.0K
May 12, 2025
Q3
2024
Sep 30, 2023
$429.0K
Nov 12, 2024
Q2
2024
Jun 30, 2023
$463.0K
Aug 8, 2024
Q1
2024
Mar 31, 2023
$297.0K
May 15, 2024
Q3
2023
Sep 30, 2022
$67.0K
Nov 9, 2023
Q2
2023
Jun 30, 2022
$237.0K
Aug 10, 2023
Q1
2023
Mar 31, 2022
$380.0K
May 15, 2023
Q3
2022
Sep 30, 2021
$984.0K
Nov 10, 2022
Q2
2022
Jun 30, 2021
$2.03M
Aug 12, 2022
Q1
2022
Mar 31, 2021
$1.12M
May 12, 2022
Q3
2021
Sep 30, 2020
$555.0K
Nov 9, 2021
Q2
2021
Jun 30, 2020
$143.0K
Aug 11, 2021
Q1
2021
Mar 31, 2020
$16.0K
May 17, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($10.85M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($9.74M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($6.67M)
May 12, 2025
Q3
2025
Sep 30, 2024
($13.49M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($4.53M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($9.13M)
May 12, 2025
Q3
2024
Sep 30, 2023
($6.49M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($8.33M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
$3.03M
May 15, 2024
Q3
2023
Sep 30, 2022
($9.33M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($8.30M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($10.29M)
May 15, 2023
Q3
2022
Sep 30, 2021
($13.80M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($10.49M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($3.92M)
May 12, 2022
Q3
2021
Feb 23, 2021
($125.0K)
Nov 9, 2021
Q3
2021
Sep 30, 2020
($6.78M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($9.11M)
Aug 11, 2021
Q1
2021
Mar 31, 2020
($7.73M)
May 17, 2021
Q3
2020
Sep 30, 2019
($5.23M)
Nov 12, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($11.05M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($9.84M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($6.80M)
May 12, 2025
Q3
2025
Sep 30, 2024
($13.52M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($4.63M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($9.27M)
May 12, 2025
Q3
2024
Sep 30, 2023
($6.51M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($8.29M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
$5.85M
May 15, 2024
Q3
2023
Sep 30, 2022
($1.71M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($1.63M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($3.02M)
May 15, 2023
Q3
2022
Sep 30, 2021
($13.60M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($13.57M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($11.36M)
May 12, 2022
Q3
2021
Feb 23, 2021
($125.0K)
Nov 9, 2021
Q3
2021
Sep 30, 2020
($6.24M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
($8.77M)
Aug 11, 2021
Q1
2021
Mar 31, 2020
($8.43M)
May 17, 2021
Q3
2020
Sep 30, 2019
($5.26M)
Nov 12, 2020